Related Experiment Video
Updated: May 28, 2026

10:11
Isolation and Identification of Limbal Niche Cells
Published on: October 27, 2023
Concise review: limbal epithelial stem cell therapy: controversies and challenges.
Anna R O'Callaghan1, Julie T Daniels
1Department of Ocular Biology & Therapeutics, University College London Institute of Ophthalmology, London, United Kingdom. anna.ocallaghan@ucl.ac.uk
Stem Cells (Dayton, Ohio)
|October 15, 2011
Summary
Limbal epithelial stem cell (LESC) therapy can restore vision by repairing the cornea. This review discusses challenges and alternative stem cell sources for treating limbal stem cell deficiency (LSCD).
Area of Science:
- Ophthalmology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Limbal epithelial stem cells (LESCs) maintain and repair the corneal surface.
- Limbal stem cell deficiency (LSCD) impairs corneal health, leading to opacity, vascularization, and inflammation.
- Cultured LESC therapy, established in 1997, utilizes patient or donor cells to treat LSCD.
Purpose of the Study:
- To review the current state of cultured LESC therapy.
- To discuss challenges and controversies in LESC therapy.
- To explore alternative stem cell sources for LSCD treatment.
Main Methods:
- Literature review of cultured LESC therapy and LSCD treatments.
- Analysis of challenges and controversies in clinical application.
- Exploration of alternative stem cell sources.
Main Results:
- Cultured LESC therapy has shown success in treating LSCD.
- Significant challenges and controversies exist within current LESC therapy protocols.
- Alternative stem cell sources are being investigated to improve treatment efficacy.
Conclusions:
- Cultured LESC therapy is a viable treatment for LSCD but faces hurdles.
- Further research into alternative stem cell sources is crucial for advancing LSCD treatment.
- Addressing current challenges will optimize the use of LESC therapy for vision restoration.
More Related Videos
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

